Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

SEC Filings

SEC Filings

Form Description Filing date View
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
8-K

Report of unscheduled material events or corporate event

View HTML
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML

Copyright Morningstar



Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved